11-119285483-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005188.4(CBL):​c.1858C>T​(p.Leu620Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00178 in 1,614,204 control chromosomes in the GnomAD database, including 70 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L620V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0019 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 65 hom. )

Consequence

CBL
NM_005188.4 missense

Scores

2
9
6

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:16O:1

Conservation

PhyloP100: 7.07

Publications

20 publications found
Variant links:
Genes affected
CBL (HGNC:1541): (Cbl proto-oncogene) This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia, and expansion of CGG repeats in the 5' UTR has been associated with Jacobsen syndrome. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Jul 2016]
CBL Gene-Disease associations (from GenCC):
  • CBL-related disorder
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, Genomics England PanelApp
  • juvenile myelomonocytic leukemia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Noonan syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007474512).
BP6
Variant 11-119285483-C-T is Benign according to our data. Variant chr11-119285483-C-T is described in ClinVar as Benign. ClinVar VariationId is 45203.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00194 (296/152360) while in subpopulation EAS AF = 0.0403 (209/5192). AF 95% confidence interval is 0.0358. There are 5 homozygotes in GnomAd4. There are 169 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 296 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005188.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CBL
NM_005188.4
MANE Select
c.1858C>Tp.Leu620Phe
missense
Exon 11 of 16NP_005179.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CBL
ENST00000264033.6
TSL:1 MANE Select
c.1858C>Tp.Leu620Phe
missense
Exon 11 of 16ENSP00000264033.3
CBL
ENST00000634586.1
TSL:5
c.1858C>Tp.Leu620Phe
missense
Exon 11 of 18ENSP00000489218.1
CBL
ENST00000637974.1
TSL:5
c.1852C>Tp.Leu618Phe
missense
Exon 11 of 17ENSP00000490763.1

Frequencies

GnomAD3 genomes
AF:
0.00194
AC:
296
AN:
152242
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00433
Gnomad EAS
AF:
0.0402
Gnomad SAS
AF:
0.00372
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00301
AC:
756
AN:
251406
AF XY:
0.00282
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.000289
Gnomad ASJ exome
AF:
0.00298
Gnomad EAS exome
AF:
0.0334
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000879
Gnomad OTH exome
AF:
0.00359
GnomAD4 exome
AF:
0.00176
AC:
2573
AN:
1461844
Hom.:
65
Cov.:
33
AF XY:
0.00175
AC XY:
1276
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.000717
AC:
24
AN:
33480
American (AMR)
AF:
0.000224
AC:
10
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00341
AC:
89
AN:
26136
East Asian (EAS)
AF:
0.0477
AC:
1895
AN:
39700
South Asian (SAS)
AF:
0.00181
AC:
156
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53388
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000594
AC:
66
AN:
1111996
Other (OTH)
AF:
0.00550
AC:
332
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
174
348
522
696
870
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00194
AC:
296
AN:
152360
Hom.:
5
Cov.:
32
AF XY:
0.00227
AC XY:
169
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41586
American (AMR)
AF:
0.000196
AC:
3
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00433
AC:
15
AN:
3468
East Asian (EAS)
AF:
0.0403
AC:
209
AN:
5192
South Asian (SAS)
AF:
0.00373
AC:
18
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68036
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0121
Hom.:
2380
Bravo
AF:
0.00169
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00287
AC:
349
Asia WGS
AF:
0.0420
AC:
144
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (8)
-
-
3
not provided (3)
-
-
1
Cardiovascular phenotype (1)
-
-
1
CBL-related disorder (1)
-
-
1
Juvenile myelomonocytic leukemia (1)
-
-
1
Juvenile myelomonocytic leukemia;C3150803:CBL-related disorder (1)
-
-
1
Noonan syndrome and Noonan-related syndrome (1)
-
-
1
RASopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.44
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Uncertain
-0.070
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.55
D
Eigen
Uncertain
0.65
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.94
D
MetaRNN
Benign
0.0075
T
MetaSVM
Benign
-0.33
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
7.1
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-0.66
N
REVEL
Uncertain
0.33
Sift
Benign
0.044
D
Sift4G
Benign
0.48
T
Polyphen
1.0
D
Vest4
0.81
MVP
0.93
MPC
0.71
ClinPred
0.013
T
GERP RS
5.2
Varity_R
0.17
gMVP
0.31
Mutation Taster
=71/29
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2227988; hg19: chr11-119156193; COSMIC: COSV50637778; COSMIC: COSV50637778; API